5-Bromo-2-((4-methoxybenzyl)oxy)pyridine

Catalog No. :
ACFLJG018
CAS No. :
663955-79-1
Molecular Formula :
C13H12BrNO2
Molecular Weight :
294.15

IUPAC Name:5-bromo-2-((4-methoxybenzyl)oxy)pyridine

5-Bromo-2-((4-methoxybenzyl)oxy)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$153.00Login to see priceInquiryInquiry
5g98%$273.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-((4-methoxybenzyl)oxy)pyridine
IUPAC Name5-bromo-2-((4-methoxybenzyl)oxy)pyridine
MDL No.MFCD08689424
Molecular FormulaC13H12BrNO2
Molecular Weight294.15
SMILESCOC1=CC=C(C=C1)COC2=NC=C(Br)C=C2
InChI KeyNCWXAIKSFAEBJX-UHFFFAOYSA-N
Synonym4-{[(5-Bromopyridin-2-yl)oxy]methyl}anisole, 1-{[(5-Bromopyridin-2-yl)oxy]methyl}-4-methoxybenzene;2-(4-methoxybenzyloxy)-5-bromopyridine;Pyridine, 5-bromo-2-[(4-methoxyphenyl)methoxy]-;5-bromo-2-[(4-methoxyphenyl)methoxy]pyridine
CAS No.663955-79-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFLJG018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCKWO017 route compound structure diagram
    ACCKWO017624-28-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFLJG018 route product structure diagram
    ACFLJG018663955-79-1
Inquiry

2. ACFLJG018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPUSF613 route compound structure diagram
    ACPUSF61349843-23-4 In Stock
  4. Then
  5. ACFLJG018 route product structure diagram
    ACFLJG018663955-79-1
Inquiry

Comments (0)